Boosters cut long COVID risk significantly

Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.

STRUCTURE and MAXA – Biotech Investments

Kuros Biosciences AG / Key word(s): Study/Study results 27-Dec-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

December 28, 2023

Key House Republican on health care plans exit from Congress

WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end

February 8, 2024

Merz makes a $185m bid for assets from bankrupt Acorda – Pharmaceutical Technology

Share this article The deal includes Inbrija (levodopa inhalation powder) and Fampyra (fampridine), the latter marketed as Ampyra (dalfampridine) in the US. Image credit: Shutterstock/Andrii

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.